Uger Robert 4
4 · Trillium Therapeutics Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Uger Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2021-03-12$3.39/sh+2,917$9,896→ 2,917 total - Sale
Common Shares
2021-03-12$11.97/sh−2,917$34,916→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-12−2,917→ 58,333 totalExercise: $3.39Exp: 2028-11-08→ Common Shares (2,917 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.8020 USD.
- [F3]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.